Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-17 Purchase | 2022-08-18 3:56 pm | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 600,000 | $0.172 | $103,200 | 780,232 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-28 Option Award | 2024-07-02 6:06 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 4,854 | $2.958 | 31,362 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 9:31 pm | N/A 2034-06-24 | Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 500,000 | $0 | 500,000 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 5:17 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 167 | $1.717 | 26,508 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 4:05 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 167 | $1.5895 | 26,341 (Direct) | View |
| 2022-12-30 Option Award | 2023-01-03 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 5,000 | $0.0876 | 785,232 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-15 4:30 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 5,000 | $0.748 | 180,232 (Direct) | View |
| 2022-05-12 Exercise | 2022-05-16 1:39 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 100,000 | $1 | 245,232 (Direct) | View |
| 2022-05-12 Exercise | 2022-05-16 1:39 pm | N/A 2029-09-05 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 100,000 | $0 | 245,232 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:14 pm | N/A 2032-03-01 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 300,000 | $0 | 300,000 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-03 4:17 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 3,623 | $1.6575 | 75,232 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 4:10 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 5,000 | $1.9465 | 71,609 (Direct) | View |
| 2021-04-23 Exercise | 2021-04-27 4:13 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 5,000 | $1.5 | 66,609 (Direct) | View |
| 2021-04-23 Exercise | 2021-04-27 4:13 pm | 2018-08-29 2021-04-26 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 5,000 | $0 | 66,609 (Direct) | View |
| 2020-12-31 Option Award | 2021-01-04 4:58 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 5,000 | $0.4521 | 361,609 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:58 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 300,000 | $0 | 361,609 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 5:20 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 5,000 | $0.448 | 56,609 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER | 300,000 | $0 | 300,000 (Direct) | View |